Skip to main content
SpringerLink
Log in

Erlotinib

Fatal interstitial lung disease: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Makris D, Scherpereel A, Copin MC, Colin G, Brun L, Lafitte JJ, Marquette CH.Fatal interstitial lung disease associated with oral erlotinib therapy for lung cancer. BMC Cancer 7: [4 pages], 5 Aug 2007. Available from: URL: http://www.biomedcentral.com/1471-2407/7/150 - France

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Erlotinib. React. Wkly. 1176, 14 (2007). https://doi.org/10.2165/00128415-200711760-00041

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200711760-00041

Keywords

Search

Navigation